Asbestos
RTECS #
CI6475000
CAS #
Updated
March 2019
Molecular Weight
N/R
Molecular Formula
N/R
Synonyms
Amianthus
Amosite (Obs.)
Amphibole
Asbest (German)
Asbestos (ACGIH:OSHA)
Asbestos fiber
Asbestos fibre
Asbestos, all forms
Fibrous grunerite
NCI C08991
Amosite (Obs.)
Amphibole
Asbest (German)
Asbestos (ACGIH:OSHA)
Asbestos fiber
Asbestos fibre
Asbestos, all forms
Fibrous grunerite
NCI C08991
Mutation Data and Reference
System Test | Route/Organism/Tissue | Dose | Reference |
---|---|---|---|
mutation in microorganisms | /Escherichia coli | 10 mg/plate (+/-enzymatic activation step) | PSEBAA 177,343,1984 |
Tumorigenic Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
implant/rat | lowest published toxic dose: 750 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Tumorigenic: Tumors at site of application | ZEKBAI 62,561,1958 |
intraperitoneal/mouse | lowest published toxic dose: 80 mg/kg | Tumorigenic: Equivocal tumorigenic agent by RTECS criteria Tumorigenic: Tumors at site of application | PAACA3 24,61,1983 |
Acute Toxicity Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
In Vitro/Human, lung tumor | Inhibitor Concentration Low: 12 mg/L/3D | In Vitro Toxicity Studies: Apoptosis in vitro | TOLED5 200,176,2011 |
In Vitro/Human, lung tumor | Inhibitor Concentration Low: 25 mg/L/6D | In Vitro Toxicity Studies: Apoptosis in vitro | TOLED5 200,176,2011 |
In Vitro/Human, lung tumor | Inhibitor Concentration Low: 7.5 mg/L/6D | In Vitro Toxicity Studies: Cell viability (mitochondrial reductase assays): MTT, XTT, MTS, WSTs assays etc. | TOLED5 200,176,2011 |
In Vitro/Mouse, macrophage | Inhibitor Concentration (50 percent kill): 340 mg/L/17H | In Vitro Toxicity Studies: Cell membrane integrity: Cytoplasmic enzymes leakage (lactate dehydrogenase, ATP enzymes etc.) | TIVIEQ 1,77,1987 |
In Vitro/Mouse, macrophage | Inhibitor Concentration Low: 35 µg/cm2/48H | In Vitro Toxicity Studies: Cell proliferation: DNA incorporation, mitotic index etc. Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TXAPA9 275,257,2014 |
inhalation/human | lowest published toxic concentration: 1.2 fiber/cubic centimeter/19Y- continuous | Lung, Thorax, or Respiration: Pleural effusion Lung, Thorax, or Respiration: Dyspnea Lung, Thorax, or Respiration: Sputum | ARDSBL 104,576,1971 |
intraperitoneal/mouse | lowest published toxic dose: 400 µg/kg | Blood: Changes in spleen Immunological Including Allergic: Increase in cellular immune response | TOXID9 -,124,2008 |
intratracheal/rat | lowest published toxic dose: 20 mg/kg | Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Multiple enzyme effects Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TOXID9 -,191,2009 |
intratracheal/rat | Lethal dose: >4 mL/kg | Lung, Thorax, or Respiration: Structural or functional change in trachea or bronchi Lung, Thorax, or Respiration: Other changes Biochemical: Enzyme inhibition, induction, or change in blood or tissue levels: Dehydrogenases | CHYCDW 32,139,1998 |
intratracheal/rat | lowest published toxic dose: 4 mg/kg | Biochemical: Metabolism (intermediary): Plasma proteins not involving coagulation Biochemical: Metabolism (intermediary): Effect on inflammation or mediation of inflammation | TXAPA9 260,105,2012 |
Other Multiple Dose Data and References
Route/Organism | Dose | Effect | Reference |
---|---|---|---|
intratracheal/mouse | lowest published toxic dose: 2400 µg/kg/1W- intermittent | TXAPA9 275,257,2014 |
Reviews
Organization | Standard | Reference |
---|---|---|
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-time-weighted average 0.1 f/cubic centimeter (resp) | DTLVS* TLV/BEI,2013 |
American Conference of Governmental Industrial Hygienists (ACGIH) | Threshold Limit Value-Confirmed human carcinogen | DTLVS* TLV/BEI,2013 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Sufficient Evidence | IMEMDT 2,17,1973 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 2,17,1973 |
International Agency for Research on Cancer (IARC) | Cancer Review:Human Sufficient Evidence | IMEMDT 14,11,1977 |
International Agency for Research on Cancer (IARC) | Cancer Review:Animal Sufficient Evidence | IMEMDT 14,11,1977 |
International Agency for Research on Cancer (IARC) | Cancer Review:Group 1 | IMSUDL 7,106,1987 |
TOXICOLOGY REVIEW | JPMSAE 64,1435,1975 | |
TOXICOLOGY REVIEW | PEDIAU 57,462,1976 | |
TOXICOLOGY REVIEW | JJOMDZ 15,808,1973 | |
TOXICOLOGY REVIEW | CANCAR 39,1792,1977 | |
TOXICOLOGY REVIEW | 85CVA2 5,55,1970 | |
TOXICOLOGY REVIEW | 31BYAP -,92,1974 | |
TOXICOLOGY REVIEW | ZHPMAT 166,113,1978 | |
TOXICOLOGY REVIEW | NOSYBW 40,311,1977 | |
TOXICOLOGY REVIEW | PEXTAR 12,102,1969 | |
TOXICOLOGY REVIEW | NTIS** CONF-691001 | |
TOXICOLOGY REVIEW | CNDIBJ 85,559,1976 | |
TOXICOLOGY REVIEW | MUREAV 566,21,2004 | |
TOXICOLOGY REVIEW | TOLED5 127,251,2002 | |
TOXICOLOGY REVIEW | TOLED5 140-141,223,2003 | |
TOXICOLOGY REVIEW | TOLED5 140-141,311,2003 | |
TOXICOLOGY REVIEW | MUREAV 567,227,2004 | |
TOXICOLOGY REVIEW | ENTOX* -,179,2005 | |
TOXICOLOGY REVIEW | MUREAV 658,124,2008 | |
TOXICOLOGY REVIEW | MUREAV 659,202,2008 | |
TOXICOLOGY REVIEW | MUREAV 659,31,2008 | |
TOXICOLOGY REVIEW | MUREAV 544,313,2003 | |
TOXICOLOGY REVIEW | MUREAV 544,385,2003 | |
TOXICOLOGY REVIEW | MUREAV 681,93,2009 | |
TOXICOLOGY REVIEW | MUREAV 681,24,2009 | |
TOXICOLOGY REVIEW | MUREAV 674,3,2009 | |
TOXICOLOGY REVIEW | MUREAV 674,62,2009 | |
TOXICOLOGY REVIEW | MUREAV 608,157,2006 | |
TOXICOLOGY REVIEW | MUREAV 579,6,2005 | |
TOXICOLOGY REVIEW | MUTAEX 23,191,2008 | |
TOXICOLOGY REVIEW | TOVEFN -,27,2009 | |
TOXICOLOGY REVIEW | MUTAEX 26,101,2011 | |
TOXICOLOGY REVIEW | MUTAEX 26,33,2011 | |
TOXICOLOGY REVIEW | MUREAV 736,122,2012 | |
TOXICOLOGY REVIEW | MUREAV 750,132,2012 | |
TOXICOLOGY REVIEW | MUTAEX 27,257,2012 | |
TOXICOLOGY REVIEW | TXAPA9 248,71,2010 | |
TOXICOLOGY REVIEW | MUREAV 744,8,2012 | |
TOXICOLOGY REVIEW | MUREAV 759,27,2014 | |
TOXICOLOGY REVIEW | MUREAV 776,118,2015 | |
TOXICOLOGY REVIEW | MUREAV 768,27,2016 | |
TOXICOLOGY REVIEW | MUREAV 768,14,2016 | |
TOXICOLOGY REVIEW | FCTOD7 86,298,2015 | |
TOXICOLOGY REVIEW | TXCYAC 313,73,2013 | |
TOXICOLOGY REVIEW | MUREAV 770,12,2016 | |
TOXICOLOGY REVIEW | MUREAV 770,106,2016 | |
TOXICOLOGY REVIEW | MUREAV 773,188,2017 | |
TOXICOLOGY REVIEW | MUREAV 774,12,2017 | |
TOXICOLOGY REVIEW | MUREAV 775,11,2018 | |
TOXICOLOGY REVIEW | FCTOD7 109,650,2017 | |
TOXICOLOGY REVIEW | TOLED5 273,69,2017 | |
TOXICOLOGY REVIEW | ANMNA* ,511,2017 | |
TOXICOLOGY REVIEW | RTOPDW 53,134,2009 | |
TOXICOLOGY REVIEW | RTOPDW 60,84,2011 | |
TOXICOLOGY REVIEW | VETODR ,215,2018 |
Standards and Regulations
Organization | Standard | Reference |
---|---|---|
Mine Safety and Health Administration (MSHA) STANDARD-air | time-weighted average 5 fb/cc (fb > 5 um) | DTLWS* 3,33,1973 |
Occupational Exposure Limit IN ARGENTINA, BULGARIA, COLOMBIA, JORDAN check ACGIH TLV; | ||
Occupational Exposure Limit IN SINGAPORE, VIETNAM check ACGIH TLV | ||
Occupational Exposure Limit-AUSTRALIA | 0.1 f/mL, JUL2008 | |
Occupational Exposure Limit-JAPAN | Occupational Exposure Limit 0.003 fcc, 1 carc, MAY2012 | |
Occupational Exposure Limit-NEW ZEALAND | carcinogen, JAN2002 | |
Occupational Exposure Limit-NORWAY | time-weighted average 0.1 fiber/cm3, JAN1999 | |
Occupational Exposure Limit-PERU | time-weighted average 0.1 fib/cc, JUL2005 | |
Occupational Exposure Limit-SWEDEN | time-weighted average 0.1 f/cc, Carcinogen, JUN2005 | |
Occupational Exposure Limit-SWITZERLAND | MAK-week 0.01 f/cc, carc 1, JAN2011 | |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Construction) | see Code of Federal Regulations (CFR) 29,1926.58 | CFRGBR 29,1926.55,1994 |
Occupational Safety and Health Administration (OSHA) Permissible Exposure Limit (Shipyards) | 8H time-weighted average 0.2 f/cc | CFRGBR 29,1915.1000,1993 |
Occupational Safety and Health Administration (OSHA)-CANCER AND LUNG DISEASE HAZARD | CFRGBR 29,1910.1001,1991 |
NIOSH Documentation and Surveillance
Organization | Standard | Reference |
---|---|---|
National Institute for Occupational Safety and Health (NIOSH) Recommended Exposure Level TO ASBESTOS-air | 100M time-weighted average 0.1 fb/cc in a 400L air sample | NIOSH* DHHS #92-100,1992 |
National Occupational Exposure Survey 1983 | Hazard Code 90310; Number of Industries 81; Total Number of Facilities 15617; Number of Occupations 86; Total Number of Employees Exposed 215265; Total Number of Female Employees Exposed 9727 | |
National Occupational Hazard Survey 1974 | Hazard Code 90310; Number of Industries 154; Total Number of Facilities 30863; Number of Occupations 117; Total Number of Employees Exposed 449904 |
Status in Federal Agencies
Page last reviewed: November 16, 2018
Content
source: National Institute for Occupational Safety and Health